The CIEN Foundation, in collaboration with several research centers across the country, is carrying out the SCAP-AD project (Cognitive Screening and Personalized Approach for Alzheimer’s and other Dementias). The aim is to improve the prevention and diagnosis of Alzheimer’s by identifying the disease in its early stages, even before symptoms become apparent. This study is led by Dr. Pascual Sánchez Juan, and one of the research collaborators is Cantabria Cohort.
The project is developing a precision medicine tool that combines several strategies to detect Alzheimer’s disease. It includes online cognitive assessments that test memory and other brain functions. In addition, it analyzes individuals’ genetic risk and examines blood biomarkers, which can indicate changes in the brain before symptoms appear. At Cantabria Cohort, we have already invited our participants aged 60 and over—currently nearly 19,000 people—to take part in the study.
The SCAP-AD project aims to develop more effective methods for identifying Alzheimer’s disease in its early stages, which could enable people to receive preventive treatments in time and improve their quality of life. This study is funded by the Carlos III Health Institute and supported by NextGenerationEU European funds, as part of the European Union’s Recovery and Resilience Facility.
More information on Fundación CIEN website.